Antimicrobial Pharmacology - USMLE Step 1

1. The drug responsible for this patient's symptoms acts by inhibiting which of the following?
   Answer: DNA gyrase and topoisomerase IV Ciprofloxacin is a fluoroquinolone antibiotic. Fluoroquinolones exert their bactericidal effect by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes necessary for DNA replication, transcription, and repair. A well-known, though rare, adverse effect of fluoroquinolones is tendonitis and tendon rupture, particularly of the Achilles tendon.
2. This combination therapy is effective due to its ability to sequentially inhibit the synthesis of which of the following essential molecules?
   Answer: Tetrahydrofolate TMP-SMX works by sequentially inhibiting two key enzymes in the bacterial and protozoal folate synthesis pathway. Sulfamethoxazole (a sulfonamide) competes with para-aminobenzoic acid (PABA) to inhibit dihydropteroate synthase. Trimethoprim inhibits dihydrofolate reductase. This dual blockade prevents the synthesis of tetrahydrofolate, a crucial cofactor for purine and thymidine synthesis, leading to a bactericidal effect.
3. The medication responsible for these adverse effects exerts its antimicrobial activity by which of the following mechanisms?
   Answer: Binding irreversibly to the 30S ribosomal subunit, causing mRNA misreading Gentamicin is an aminoglycoside. These antibiotics bind irreversibly to the 16S rRNA of the 30S ribosomal subunit, which leads to misreading of the mRNA codon and the production of faulty proteins, as well as premature termination of translation. Ototoxicity and nephrotoxicity are well-known adverse effects of aminoglycosides.
4. What is the mechanism of action of this antifungal agent?
   Answer: Inhibition of the synthesis of beta-(1,3)-D-glucan Caspofungin is an echinocandin antifungal. Echinocandins work by noncompetitively inhibiting the enzyme beta-(1,3)-D-glucan synthase. This disrupts the synthesis of beta-glucan, an essential polysaccharide component of the fungal cell wall (but not human cells). The resulting weakened cell wall leads to osmotic instability and fungal cell death.
5. The bactericidal effect of ceftriaxone is due to its ability to inhibit which of the following processes?
   Answer: Peptidoglycan cross-linking Ceftriaxone is a third-generation cephalosporin, which is a class of beta-lactam antibiotics. Like other beta-lactams, its mechanism of action involves binding to and inactivating penicillin-binding proteins (PBPs), primarily transpeptidases. This inhibition prevents the final cross-linking step of peptidoglycan synthesis, compromising the integrity of the bacterial cell wall and leading to bacteriolysis.
6. This medication exerts its antifungal effect by inhibiting a fungal cytochrome P450 enzyme, which directly blocks the synthesis of which of the following essential membrane components?
   Answer: Ergosterol Fluconazole is an azole antifungal agent. Azoles work by inhibiting the fungal cytochrome P450 enzyme 14-alpha-demethylase. This enzyme is responsible for converting lanosterol to ergosterol. The subsequent depletion of ergosterol and accumulation of toxic sterol precursors disrupt the structure and function of the fungal cell membrane.
7. A Gram-negative rod is ceftriaxone resistant; clavulanate restores susceptibility. Which mechanism is present?
   Answer: ESBL beta-lactamase present Clavulanate inhibits ESBL enzymes, so ceftriaxone resistance that disappears when clavulanate is added points to ESBL. AmpC is the tempting wrong answer, but clavulanate does not reliably inhibit AmpC beta-lactamases, so it would not restore susceptibility. KPC carbapenemase and porin loss also do not fit this clavulanate effect.
8. What is the mechanism of action of sofosbuvir?
   Answer: Inhibition of the viral NS5B RNA-dependent RNA polymerase Sofosbuvir is a nucleotide analog prodrug that, once metabolized to its active triphosphate form, acts as a potent inhibitor of the HCV NS5B protein. NS5B is an RNA-dependent RNA polymerase that is essential for the replication of the viral genome. By inhibiting this enzyme, sofosbuvir acts as a chain terminator, halting viral replication.
9. A 45-year-old construction worker with onychomycosis is prescribed terbinafine. Which step in fungal physiology is directly inhibited by this medication?
   Answer: Squalene epoxidase converts squalene to squalene-2,3-epoxide in the ergosterol pathway When you encounter antifungal medications on Step 1, focus on their specific targets in fungal cell membrane synthesis. Fungi rely on ergosterol (not cholesterol like humans) for membrane integrity, making this pathway an excellent therapeutic target. Terbinafine is an allylamine antifungal that specifically inhibits squalene epoxidase, the enzyme that converts squalene to squalene-2,3-epoxide in the ergosterol biosynthesis pathway. This blockade causes toxic squalene accumulation within fungal cells while preventing ergosterol formation, leading to defective cell membranes and fungal death. This mechanism makes terbinafine particularly effective for dermatophyte infections like onychomycosis. Looking at the wrong answers: (B) describes the mechanism of azole antifungals (fluconazole, itraconazole), which inhibit 14-α-demethylase and block ergosterol synthesis at a different step. (C) refers to echinocandins (caspofungin, micafungin), which target fungal cell wall synthesis by inhibiting β-1,3-glucan synthase—this affects the cell wall, not the membrane. (D) describes flucytosine's mechanism, where fungal cytosine deaminase converts it to toxic 5-fluorouracil, disrupting RNA and DNA synthesis. Remember that antifungal mechanisms cluster around three main targets: ergosterol synthesis (terbinafine and azoles at different steps), cell wall synthesis (echinocandins), and nucleic acid synthesis (flucytosine). For Step 1, memorize which drug hits which specific enzyme—this pattern appears frequently in pharmacology questions about antimicrobial selectivity.
10. This drug is effective against dermatophytes because it inhibits which of the following fungal enzymes?
    Answer: Squalene epoxidase Terbinafine is an allylamine antifungal that works by inhibiting squalene epoxidase, a key enzyme in the ergosterol synthesis pathway. This inhibition leads to a deficiency of ergosterol and a toxic accumulation of squalene within the fungal cell, which disrupts membrane function and leads to cell death. Terbinafine is highly lipophilic and keratophilic, allowing it to concentrate in nails and skin.
11. An isolate has MIC 0.5 µg/mL and MBC 32 µg/mL. What best describes the agent?
    Answer: Bacteriostatic at 0.5 µg/mL The MBC is 64-fold higher than the MIC (32 / 0.5 = 64), so the concentration that stops growth does not kill the organism; the drug is bacteriostatic at the MIC. Bactericidal at 0.5 is tempting, but bactericidal agents have an MBC close to the MIC, usually within 4-fold, not 64-fold apart.
12. Which resistance mechanism is inhibited by clavulanate?
    Answer: ESBL beta-lactamases Clavulanate blocks beta-lactamase enzymes that would otherwise destroy penicillins, and extended-spectrum beta-lactamases (ESBLs) are among the enzymes it inhibits. The tempting wrong answer is AmpC beta-lactamases, but AmpC enzymes are generally not inhibited by clavulanate, so that mechanism does not fit.
13. This drug helps to limit the severity and duration of the illness by inhibiting which of the following viral functions?
    Answer: Release of newly formed virions from the infected cell Oseltamivir is a neuraminidase inhibitor. Neuraminidase is a viral enzyme on the surface of the influenza virus that cleaves sialic acid residues on the host cell membrane. This cleavage is necessary for the release of newly synthesized viral particles from the infected cell, allowing them to spread to other cells. By inhibiting neuraminidase, oseltamivir traps the virions on the cell surface, preventing propagation of the infection.
14. A 35-year-old Peace Corps volunteer in West Africa is diagnosed with onchocerciasis (river blindness) due to Onchocerca volvulus. Which medication should be administered, and what is its primary mechanism of action against the parasite?
    Answer: Ivermectin, which activates glutamate-gated chloride channels causing parasite paralysis and death When you encounter questions about parasitic infections and their treatments, focus on matching the specific parasite with its corresponding drug and mechanism of action. This is a high-yield topic that requires memorizing key drug-parasite pairs. Onchocerca volvulus causes onchocerciasis (river blindness), a filarial infection transmitted by blackflies near rivers in Africa and Central America. The first-line treatment is ivermectin, which works by binding to glutamate-gated chloride channels in nematode nerve and muscle cells. This binding causes chloride influx, leading to hyperpolarization, paralysis, and death of the microfilariae (larval stage). Ivermectin is particularly effective against the microfilariae rather than adult worms, making it ideal for reducing transmission and preventing blindness. Choice B describes praziquantel's mechanism, which targets trematodes and cestodes (flukes and tapeworms), not nematodes like Onchocerca. Choice C describes albendazole, a benzimidazole that disrupts microtubules in various helminths but is not first-line for onchocerciasis. Choice D describes metronidazole's mechanism against anaerobic bacteria and protozoa like Giardia and Trichomonas, not helminths. For USMLE Step 1, memorize these key associations: ivermectin for filarial nematodes (Onchocerca, Wuchereria), praziquantel for flatworms, albendazole for tissue nematodes and some cestodes, and metronidazole for anaerobic protozoa. The glutamate-gated chloride channel mechanism is unique to ivermectin and explains its selectivity for invertebrates over mammals.
15. What does linezolid added to an SSRI most likely cause?
    Answer: Serotonin syndrome Linezolid inhibits monoamine oxidase, and adding it to an SSRI traps serotonin, so you get serotonin syndrome with fever, clonus, and agitation. The tempting pick is hypertensive crisis, but that requires tyramine-rich foods or sympathomimetics, not an SSRI.
16. This antibiotic is considered safe in this patient because its monocyclic beta-lactam structure has minimal cross-reactivity with penicillins. However, it shares a common mechanism of action with penicillins by targeting which of the following?
    Answer: Penicillin-binding proteins Aztreonam is a monobactam, a class of beta-lactam antibiotics. Its mechanism of action is identical to other beta-lactams: it binds to penicillin-binding proteins (specifically PBP3 in gram-negative rods) and inhibits peptidoglycan synthesis. Its unique monocyclic structure (lacking the fused thiazolidine or dihydrothiazine ring of other beta-lactams) is responsible for its lack of cross-allergenicity with penicillins and cephalosporins, making it a safe choice for patients with a history of severe penicillin allergy.
17. Which of the following best describes the mechanism of action of the prescribed drug against this anaerobic protozoan?
    Answer: Formation of cytotoxic free radicals that disrupt DNA Metronidazole is a prodrug that is selectively taken up by anaerobic bacteria and protozoa. Once inside the organism, its nitro group is reduced by anaerobic electron transport proteins like ferredoxin. This reduction process creates highly reactive, cytotoxic free radicals that bind to and damage the organism's DNA, leading to cell death.
18. A 59-year-old man with hepatitis C genotype 1 infection is started on a regimen that includes sofosbuvir. Which viral process is most directly inhibited by this agent?
    Answer: RNA-dependent RNA polymerase mediates chain elongation during viral genome replication When you encounter questions about hepatitis C antiviral medications, focus on identifying which specific step of the viral life cycle each drug targets. Sofosbuvir is a nucleotide analog that specifically disrupts viral genome replication. Sofosbuvir works as a nucleotide analog inhibitor of the hepatitis C virus NS5B RNA-dependent RNA polymerase. Once phosphorylated to its active triphosphate form, sofosbuvir gets incorporated into the growing viral RNA chain during replication. This incorporation causes premature chain termination because sofosbuvir lacks the 3'-OH group necessary for further nucleotide addition. The RNA-dependent RNA polymerase cannot continue elongating the viral genome, effectively halting viral replication. This makes choice A correct. Choice B describes the NS3/4A protease, which is targeted by different HCV drugs like telaprevir and boceprevir, not sofosbuvir. Choice C refers to the NS5A protein, which is inhibited by drugs like ledipasvir and daclatasvir - these are often combined with sofosbuvir in treatment regimens but represent a different mechanism. Choice D describes viral entry into hepatocytes, which occurs much earlier in the viral life cycle and isn't affected by sofosbuvir. Remember that modern HCV treatment often uses combination therapy targeting multiple steps simultaneously. When studying antiviral mechanisms, categorize drugs by which viral enzyme or process they inhibit: polymerase inhibitors (sofosbuvir), protease inhibitors (telaprevir), or NS5A inhibitors (ledipasvir). This framework will help you quickly identify the correct mechanism for any HCV drug question.
19. Which of the following is the mechanism of action of the prescribed antibiotic?
    Answer: Binding to the 50S ribosomal subunit to inhibit translocation Azithromycin is a macrolide antibiotic. Macrolides work by binding to the 23S rRNA of the 50S ribosomal subunit, which blocks the exit tunnel and inhibits the translocation step of protein synthesis, effectively halting bacterial protein production.
20. A hospitalized patient with ventilator-associated pneumonia due to extended-spectrum β-lactamase (ESBL)–producing Klebsiella pneumoniae is started on piperacillin combined with tazobactam. Resistance testing shows the organism produces a plasmid-encoded class A serine β-lactamase. Which of the following best describes the action of tazobactam that allows piperacillin to regain activity?
    Answer: It irreversibly acylates a serine residue in the active site of the β-lactamase enzyme, preventing hydrolysis of the antibiotic When you encounter questions about β-lactamase inhibitors like tazobactam, focus on their mechanism of action as "suicide inhibitors" that protect β-lactam antibiotics from enzymatic destruction. ESBL-producing bacteria like this Klebsiella pneumoniae render β-lactam antibiotics ineffective by producing enzymes that cleave the β-lactam ring. Tazobactam works as a β-lactamase inhibitor by irreversibly binding to the enzyme's active site. It contains a β-lactam-like structure that acts as a decoy substrate. When the β-lactamase attempts to hydrolyze tazobactam, it forms a covalent bond with a serine residue in the enzyme's active site, permanently inactivating the enzyme. This "suicide inhibition" prevents the β-lactamase from destroying piperacillin, allowing the antibiotic to reach its target penicillin-binding proteins and inhibit cell wall synthesis. Choice A correctly describes this irreversible acylation mechanism. Choice B incorrectly describes the action of β-lactam antibiotics themselves, not β-lactamase inhibitors. Choice C misrepresents tazobactam's function—it doesn't block porins or affect efflux pumps. Choice D describes a nonsensical mechanism; tazobactam doesn't induce AmpC expression, and such induction wouldn't be therapeutically beneficial. Remember that β-lactamase inhibitors like tazobactam, sulbactam, and clavulanate all work through irreversible enzyme inhibition. When you see combination drugs like piperacillin-tazobactam, think "suicide inhibitor protecting the antibiotic." This mechanism is crucial for treating infections caused by β-lactamase-producing organisms.

Start this quiz